Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease  Kristin Kaasen Jørgensen,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Inger Camilla Solberg, Morten H
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Millie D. Long, Bruce E. Sands 
Pichamol Jirapinyo, Christopher C. Thompson 
Coordinating Care in Patients With Cirrhosis
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
A Shocking Cystory Clinical Gastroenterology and Hepatology
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist  Rahima A. Bhanji, Elizabeth J. Carey,
Factors Related to Fatigue in Patients With Cirrhosis Before and After Liver Transplantation  Evangelos Kalaitzakis, Axel Josefsson, Maria Castedal, Pia.
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
Inger Camilla Solberg, Morten H
Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis  Ina Marie Andersen, Guro Tengesdal, Benedicte Alexandra.
Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review  Marin J. de Jong,
Diagnostic Accuracy of Magnetic Resonance and Endoscopic Retrograde Cholangiography in Primary Sclerosing Cholangitis  Audun Elnaes Berstad, Lars Aabakken,
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Evidence for Life Before Inflammatory Bowel Disease
A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease  Garret Cullen, Denise Keegan, Hugh.
Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma  Emmanouil Sinakos,
Issue Highlights Clinical Gastroenterology and Hepatology
The Natural History of Small-Duct Primary Sclerosing Cholangitis
Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease  Corey A. Siegel, John I. Allen, Gil.
Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased  Fiona D.M. van Schaik, Martijn G.H.
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis  Jing Hieng Ngu, Richard Blair Gearry, Andrew.
New Models of Gastroenterology Practice
Ramesh Kumar, Masiullah, Pintu Kumar Singh 
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Endoscopic Ultrasound–Guided Cholecystoduodenostomy for Acute Cholecystitis in a Patient With Thrombocytopenia and End-Stage Liver Disease Awaiting Transplantation 
Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A. Moum, Morten H. Vatn 
Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis  Erin W. Thackeray, Phunchai Charatcharoenwitthaya,
David H. Bruining, William J. Sandborn 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Volume 133, Issue 2, Pages (August 2007)
Patient-Reported Outcomes of Cirrhosis
Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease  Kristin Kaasen Jørgensen,
Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease  Aoibhlinn O'Toole, Alaa Alakkari, Denise Keegan, Glen Doherty, Hugh.
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis  Lina Lindström, Rolf Hultcrantz,
Volume 151, Issue 4, Pages (October 2016)
Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis 
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis 
Thrombocytopenia With Abnormal Liver Function Tests
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Christopher Hung, Desmond Leddin 
A 42–Year–Old Woman With a New Diagnosis of Sclerosing Cholangitis
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
Issue Highlights Clinical Gastroenterology and Hepatology
Reduced Coffee Consumption Among Individuals With Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis  Craig Lammert, Brian D. Juran, Erik.
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis  Knut Stokkeland, Jonas Höijer, Matteo Bottai, Karin Söderberg-Löfdal,
Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N
Presentation transcript:

Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease  Kristin Kaasen Jørgensen, Lina Lindström, Milada Cvancarova, Tom H. Karlsen, Maria Castedal, Styrbjörn Friman, Erik Schrumpf, Aksel Foss, Helena Isoniemi, Arno Nordin, Kathrine Holte, Allan Rasmussen, Annika Bergquist, Morten H. Vatn, Kirsten Muri Boberg  Clinical Gastroenterology and Hepatology  Volume 11, Issue 5, Pages 517-523 (May 2013) DOI: 10.1016/j.cgh.2012.12.027 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Five predefined curves depicting the course of IBD from diagnosis of IBD until Ltx (pre Ltx), and from Ltx until last follow-up evaluation (post Ltx). Recordings were based on the investigators' impression of the overall course of IBD in each patient. In the pre Ltx evaluation, the end of the curves represents disease activity at Ltx. In the post Ltx evaluation, the end of the curves represents disease activity at last clinical follow-up. *Including 20 colectomies. Clinical Gastroenterology and Hepatology 2013 11, 517-523DOI: (10.1016/j.cgh.2012.12.027) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Frequency and severity of IBD activity in PSC patients (n = 218) before and after Ltx. Clinical Gastroenterology and Hepatology 2013 11, 517-523DOI: (10.1016/j.cgh.2012.12.027) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Number of relapses per person-year during the last 3 years before and the first 3 years after Ltx (n = 186). Clinical Gastroenterology and Hepatology 2013 11, 517-523DOI: (10.1016/j.cgh.2012.12.027) Copyright © 2013 AGA Institute Terms and Conditions